(Q40286324)

English

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.

scientific article published on 18 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

phase II clinical trial

0 references

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

E Gabriela Chiorean

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sonal Sanghani

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Marissa A Schiel

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Menggang Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Matthew Burns

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yan Tong

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

David T Hinkle

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Nicki Coleman

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bruce Robb

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Julia LeBlanc

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Romnee Clark

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jose Bufill

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Colleen Curie

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Patrick J Loehrer

14

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Higinia Cardenes

15

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

18 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

25-32

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Expression and characterization of a human carboxylesterase 2 splice variant.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Downregulation of topoisomerase I in differentiating human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Human carboxylesterases: an update on CES1, CES2 and CES3.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, [...]

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1883-1

21 January 2018

Identifiers

10.1007/S00280-012-1883-1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40286324&oldid=2203570161"